News
She took care of you for years. Now it is time to turn the caregiving tables by giving your mom these 5 health check ups.
A new treatment nearly halves the risk of disease progression or death from a less common form of breast cancer that hasn't ...
Increased consumption of olive oil may reduce the risk for specific subtypes of breast cancer, according to results of a prospective study.
Charities and campaigners said the new findings add to the 'betrayal' that they cannot get the life-extending drug on the NHS ...
CNBC's Angelica Peebles and AstraZeneca CEO Pascal Soriot join 'Squawk Box' to discuss the company's breast cancer drug trial ...
The 22-year-old Phuket native – who speaks Mandarin, English and Thai – plans to use her new platform to champion breast ...
Panelists discuss how a multidisciplinary team approach to patient education and medication management is crucial for ensuring adherence and optimal outcomes with oral medications like elacestrant.
Clairity has received U.S. FDA De Novo authorization for CLAIRITY BREAST, a prognostic platform designed to predict five-year ...
AstraZeneca Plc and Daiichi Sankyo Co.’s Enhertu delayed the advance of a common type of breast cancer by more than a year in ...
Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced the launch of a new ...
Trastuzumab deruxtecan plus pertuzumab demonstrated statistically and clinically significant improvement in progression-free ...
AstraZeneca and Daiichi Sankyo’s Enhertu plus Roche’s Perjeta demonstrated the potential to shake up first-line treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results